✦ LIBER ✦

Resistance of rheumatoid arthritis patients to changing therapy: Discordance between disease activity and patients' treatment choices

✍ Scribed by Frederick Wolfe; Kaleb Michaud

Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 109 KB
Volume: 56
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.22719

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Determinants of discordance in patients'

Determinants of discordance in patients' and physicians' rating of rheumatoid arthritis disease activity

✍ Nasim A. Khan; Horace J. Spencer; Esam Abda; Amita Aggarwal; Rieke Alten; Codrin 📂 Article 📅 2012 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 251 KB 👁 2 views

## Abstract ## Objective To assess the determinants of patients' (PTGL) and physicians' (MDGL) global assessment of rheumatoid arthritis (RA) activity and factors associated with discordance among them. ## Methods A total of 7,028 patients in the Quantitative Standard Monitoring of Patients with

Failure of low-dose intravenous immunogl

Failure of low-dose intravenous immunoglobulin therapy to suppress disease activity in patients with treatment-refractory rheumatoid arthritis

✍ Keith S. Kanik; Cheryl H. Yarboro; Yaakov Naparstek; Paul H. Plotz; Ronald L. Wi 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 262 KB 👁 2 views

Treatment with high-dose (400 mg/kg/ day) intravenous immunoglobulin ( M g ) shows benefit in many autoimmune diseases but is very expensive. Low-dose M g has also been shown to be effective in inhibiting adjuvant arthritis in the rat. This pilot, randomized, double-blind, placebo-controlled trial w

Disease activity early in the course of

Disease activity early in the course of treatment predicts response to therapy after one year in rheumatoid arthritis patients

✍ Daniel Aletaha; Julia Funovits; Edward C. Keystone; Josef S. Smolen 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 1 views

Five-year followup of rheumatoid arthrit

Five-year followup of rheumatoid arthritis patients after early treatment with disease-modifying antirheumatic drugs versus treatment according to the pyramid approach in the first year

✍ Suzan M. M. Verstappen; Johannes W. G. Jacobs; Johannes W. J. Bijlsma; Anton H. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 2 views

## Abstract ## Objective To evaluate whether the clinical advantages observed after 1 year in a randomized controlled clinical trial, in which 2 treatment strategies were compared (the early disease‐modifying antirheumatic drug [DMARD] approach versus the pyramid approach), persist after 5 years.

Changes in hand bone mineral density and

Changes in hand bone mineral density and the association with the level of disease activity in patients with rheumatoid arthritis: Bone mineral density measurements in a multicenter randomized clinical trial

✍ L. Dirven; M. Güler-Yüksel; W. M. de Beus; H. K. Ronday; I. Speyer; T. W. J. Hui 📂 Article 📅 2011 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 139 KB 👁 2 views

RAPID3 (Routine Assessment of Patient In

RAPID3 (Routine Assessment of Patient Index Data 3) severity categories and response criteria: Similar results to DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) in the RAPID 1 (Rheumatoid Arthritis Prevention of Structural Damage) clinical trial of certolizumab pegol

✍ Theodore Pincus; Victoria Furer; Edward Keystone; Yusuf Yazici; Martin J. Bergma 📂 Article 📅 2011 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 150 KB 👁 2 views